JPM vs NFJ
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NFJ presents a stable financial profile with a Piotroski F-Score of 5/9 and a valuation that sits comfortably between its growth-based intrinsic value ($11.13) and its defensive Graham Number ($22.31). While the fund exhibits strong recent price momentum and an attractive 8.60% dividend yield, the technical trend score is severely bearish (10/100), suggesting a potential divergence or upcoming correction. The low P/E ratio of 8.92 relative to the sector average of 34.42 indicates significant undervaluation, though the lack of growth data limits a bullish conviction.
Compare Another Pair
Related Comparisons
JPM vs NFJ: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Virtus Dividend, Interest & Premium Strategy Fund (NFJ) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.